Hart SL - Search Results

1

Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice.

Alton EW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, Jeffery PK, Geddes DM, Hart SL, Williamson R, et al. Alton EW, et al. Among authors: hart sl. Nat Genet. 1993 Oct;5(2):135-42. doi: 10.1038/ng1093-135. Nat Genet. 1993. PMID: 7504552

2

Gene therapy for cystic fibrosis.

Coutelle C, Caplen N, Hart S, Huxley C, Williamson R. Coutelle C, et al. Arch Dis Child. 1993 Apr;68(4):437-40. doi: 10.1136/adc.68.4.437. Arch Dis Child. 1993. PMID: 8503661 Free PMC article. No abstract available.

3

The introduction of two silent mutations into a CFTR cDNA construct allows improved detection of exogenous mRNA in gene transfer experiments.

Hart SL, Mayall E, Stern M, Munkonge FM, Frost A, Huang L, Vasilliou M, Williamson R, Alton EW, Coutelle C. Hart SL, et al. Hum Mol Genet. 1995 Sep;4(9):1597-602. doi: 10.1093/hmg/4.9.1597. Hum Mol Genet. 1995. PMID: 8541845

4

Gene delivery and expression mediated by an integrin-binding peptide.

Hart SL, Harbottle RP, Cooper R, Miller A, Williamson R, Coutelle C. Hart SL, et al. Gene Ther. 1995 Oct;2(8):552-4. Gene Ther. 1995. PMID: 8593606

5

Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide.

Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, Williamson R, Coutelle C. Hart SL, et al. J Biol Chem. 1994 Apr 29;269(17):12468-74. J Biol Chem. 1994. PMID: 8175653 Free article.

6

An integrin-targeted non-viral vector for pulmonary gene therapy.

Jenkins RG, Herrick SE, Meng QH, Kinnon C, Laurent GJ, McAnulty RJ, Hart SL. Jenkins RG, et al. Among authors: hart sl. Gene Ther. 2000 Mar;7(5):393-400. doi: 10.1038/sj.gt.3301095. Gene Ther. 2000. PMID: 10694821

7

Genetic therapies for cystic fibrosis lung disease.

Hart SL, Harrison PT. Hart SL, et al. Curr Opin Pharmacol. 2017 Jun;34:119-124. doi: 10.1016/j.coph.2017.10.006. Epub 2017 Nov 5. Curr Opin Pharmacol. 2017. PMID: 29107808 Review.

8

New approaches to genetic therapies for cystic fibrosis.

Christopher Boyd A, Guo S, Huang L, Kerem B, Oren YS, Walker AJ, Hart SL. Christopher Boyd A, et al. Among authors: hart sl. J Cyst Fibros. 2020 Mar;19 Suppl 1:S54-S59. doi: 10.1016/j.jcf.2019.12.012. Epub 2020 Jan 13. J Cyst Fibros. 2020. PMID: 31948871 Free article. Review.

9

In vitro platform to model the function of ionocytes in the human airway epithelium.

Vilà-González M, Pinte L, Fradique R, Causa E, Kool H, Rodrat M, Morell CM, Al-Thani M, Porter L, Guo W, Maeshima R, Hart SL, McCaughan F, Granata A, Sheppard DN, Floto RA, Rawlins EL, Cicuta P, Vallier L. Vilà-González M, et al. Among authors: hart sl. Respir Res. 2024 Apr 25;25(1):180. doi: 10.1186/s12931-024-02800-7. Respir Res. 2024. PMID: 38664797 Free PMC article.

10

An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery.

Harbottle RP, Cooper RG, Hart SL, Ladhoff A, McKay T, Knight AM, Wagner E, Miller AD, Coutelle C. Harbottle RP, et al. Among authors: hart sl. Hum Gene Ther. 1998 May 1;9(7):1037-47. doi: 10.1089/hum.1998.9.7-1037. Hum Gene Ther. 1998. PMID: 9607415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters